Photocure ASA
Develops and commercializes photodynamic technology for bladder cancer.
PHO | OL
Overview
Corporate Details
- ISIN(s):
- NO0010000045
- LEI:
- 5967007LIEEXZXG8OW35
- Country:
- Norway
- Address:
- HOFFSVEIEN 4, 0275 OSLO
- Website:
- https://www.photocure.com/
- Sector:
- Manufacturing
Description
Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-04 06:00 |
Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in …
|
English | 10.4 KB | ||
| 2024-05-23 17:33 |
Photocure ASA - Annual general meeting held
|
English | 709.6 KB | ||
| 2024-05-23 17:33 |
Photocure ASA - Annual general meeting held
|
English | 106.1 KB | ||
| 2024-05-23 17:33 |
Photocure ASA - Annual general meeting held
|
English | 1.2 KB | ||
| 2024-05-15 06:00 |
Photocure ASA: Results for the first quarter of 2024
|
English | 723.4 KB | ||
| 2024-05-15 06:00 |
Photocure ASA: Results for the first quarter of 2024
|
English | 1.2 MB | ||
| 2024-05-15 06:00 |
Photocure ASA: Results for the first quarter of 2024
|
English | 176.2 KB | ||
| 2024-05-15 06:00 |
Photocure ASA: Results for the first quarter of 2024
|
English | 6.3 KB | ||
| 2024-05-12 08:24 |
Photocure Partner Asieris announces New Drug Application acceptance for regulat…
|
English | 109.2 KB | ||
| 2024-05-12 08:24 |
Photocure Partner Asieris announces New Drug Application acceptance for regulat…
|
English | 4.8 KB | ||
| 2024-05-08 20:36 |
Photocure ASA: Invitation to presentation of first quarter 2024 financial resul…
|
English | 2.0 KB | ||
| 2024-05-07 06:00 |
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detect…
|
English | 164.5 KB | ||
| 2024-05-07 06:00 |
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detect…
|
English | 10.2 KB | ||
| 2024-04-30 11:49 |
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
|
English | 684.4 KB | ||
| 2024-04-30 11:49 |
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
|
Norwegian | 684.9 KB |
Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Photocure ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Photocure ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
